Is Krsnaa Diagnost. overvalued or undervalued?

Nov 11 2025 08:13 AM IST
share
Share Via
As of November 10, 2025, Krsnaa Diagnostics is fairly valued with a PE ratio of 29.94 and an attractive valuation grade, despite a year-to-date return of -11.31% compared to the Sensex's 6.91%.
As of 10 November 2025, Krsnaa Diagnostics has moved from a very attractive to an attractive valuation grade. The company is currently considered fairly valued. Key ratios include a PE ratio of 29.94, an EV to EBITDA of 15.77, and a Price to Book Value of 0.27.

In comparison to its peers, Krsnaa Diagnostics has a lower PE ratio than Max Healthcare, which stands at 88.71, and a more favorable EV to EBITDA ratio compared to Apollo Hospitals at 28.24. Despite the recent underperformance against the Sensex, with a year-to-date return of -11.31% compared to the Sensex's 6.91%, the company's valuation metrics suggest it is positioned well within the healthcare services sector.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News